Erythin Powder for Suspension: Each 5ml contains Erythromycin 125mg as Ethylsuccinate USP.
Erythin 500mg Tablet: Each tablet contains Erythromycin 500mg as Ethylsuccinate USP.
Erythromycin is an azalide, derived from the macrolide class of antibiotics.
Adult and child over 1 years: 250 to 500mg tablet every 6 hourly or 500mg to 1g every 12 hourly. In case of severe infection 4g daily. In case of early syphilis, 500mg tablet 4 times daily for 14 days. Uncomplicated genital chlamydia, nongonococcal urethritis, 500mg tablet twice daily for 14 days. Child: The usual dose is 30 to 50mg/kg/day in divided doses. Doses should be doubled for severe infections. Children 2 to 8 years: 250mg every 6 hourly. Children up to 2 years: 125mg every 6 hourly.
Potent CYP3A4 inhibitor: increases levels of simvastatin, carbamazepine, theophylline, cyclosporine, and warfarin; contraindicated with astemizole, terfenadine, pimozide, and ergotamine (fatal arrhythmias/ergotism).
Erythromycin is contraindicated in patients with known hypersensitivity to this antibiotic. it is also contraindicated in patients taking terfenadine, astemizole, or cisapride. Precautions: Erythromycin should be given with care in patients with impaired hepatic function.
Common: Diarrhea, vomiting, stomach cramps, mild skin rash.
Overdose
Erythromycin should be discontinued in case of overdosage. Overdosage should be handled with the prompt elimination of unabsorbed drug and all other appropriate measures. Erythromycin is not removed by peritoneal dialysis or hemodialysis.
Category C. Inadequate well-controlled studies in pregnant women; use only if potential maternal benefit outweighs fetal risk. Lactation: Excretion in human milk unknown; caution should be exercised.
No Data
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.